BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2370616)

  • 1. Totally implantable vascular access devices in cystic fibrosis: a four-year experience with fifty-eight patients.
    Morris JB; Occhionero ME; Gauderer MW; Stern RC; Doershuk CF
    J Pediatr; 1990 Jul; 117(1 Pt 1):82-5. PubMed ID: 2370616
    [No Abstract]   [Full Text] [Related]  

  • 2. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
    Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
    Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Totally implantable venous access devices in adult patients with cystic fibrosis.
    Yung B; Campbell IA; Elborn JS; Harvey JS; Shale DJ
    Respir Med; 1996 Jul; 90(6):353-6. PubMed ID: 8759479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis.
    Ball AB; Duncan FR; Foster FJ; Davidson TI; Watkins RM; Hodson ME
    Respir Med; 1989 Sep; 83(5):429-31. PubMed ID: 2616827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two percutaneous intravenous "midline" catheters in cystic fibrosis.
    Lacy DE; Spencer DA; Venkataraman M; Ruiz G; Weller PH
    J Intraven Nurs; 1996; 19(1):28-31. PubMed ID: 8708839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions.
    Rodgers HC; Liddle K; Nixon SJ; Innes JA; Greening AP
    Eur Respir J; 1998 Jul; 12(1):217-20. PubMed ID: 9701441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of an implantable venous access device in the groin using inferior epigastric vein.
    Singh SJ; Martin HC
    J Pediatr Surg; 2001 Apr; 36(4):579-81. PubMed ID: 11283881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silastic catheters for home antibiotic therapy in patients with cystic fibrosis.
    Buck C; Holl R; Kohne E; Wolf A
    Eur J Pediatr; 1997 Mar; 156(3):209-11. PubMed ID: 9083762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of peripherally inserted central catheters in adults with cystic fibrosis or bronchiectasis.
    Dupont C; Gouya H; Panzo R; Hubert D; Correas JM; Agrario L; Chapron J; Honoré I; Kanaan R; Legmann P; Dusser D; Vignaux O; Burgel PR
    J Vasc Access; 2015; 16(3):245-9. PubMed ID: 25656251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silastic catheters for antibiotics in cystic fibrosis.
    Williams J; Smith HL; Woods CG; Weller PH
    Arch Dis Child; 1988 Jun; 63(6):658-9. PubMed ID: 3389899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two types of catheters through femoral vein catheterization in patients with lung cancer undergoing chemotherapy: A retrospective study.
    Xu B; Zhang J; Tang S; Hou J; Ma M
    J Vasc Access; 2018 Nov; 19(6):651-657. PubMed ID: 29701120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five years' experience of PAS Port intravenous access system in adult cystic fibrosis.
    Burdon J; Conway SP; Murchan P; Lansdown M; Kester RC
    Eur Respir J; 1998 Jul; 12(1):212-6. PubMed ID: 9701440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Underestimation of total cost and other possible uses of the nontunneled silastic catheters.
    Scarpinato L
    Arch Intern Med; 1994 May; 154(9):1038. PubMed ID: 8179449
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of totally implantable vascular access devices in patients with cystic fibrosis.
    Dal Molin A; Gatta C; Festini F
    Minerva Pediatr; 2009 Oct; 61(5):549-55. PubMed ID: 19794380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete catheter disconnection and migration of an implantable venous access device: the disconnected cap sign.
    Faraj W; Zaghal A; El-Beyrouthy O; Kutoubi A
    Ann Vasc Surg; 2010 Jul; 24(5):692.e11-5. PubMed ID: 20413259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study.
    Dal Molin A; Di Massimo DS; Braggion C; Bisogni S; Rizzi E; D'Orazio C; Di Toppa MV; Alghisi F; Cristadoro S; Carnovale V; Festa G; Rampini S; Colombo C; Oneta A; Furnari ML; Calamia MA; Zunino ML; Tuccio G; Spadea V; Messore B; Grosso B; Festini F
    J Vasc Access; 2012; 13(3):290-5. PubMed ID: 22266592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stuck long-term indwelling central venous catheters in adolescents: three cases and a short topical review.
    Mortensen A; Afshari A; Henneberg SW; Hansen MA
    Acta Anaesthesiol Scand; 2010 Jul; 54(6):777-80. PubMed ID: 20455871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mystery of the occluded port that allowed blood withdrawal: is it safe to use standard needles to access ports? A case report and literature review.
    Cataldo R; Costa F; Vitiello M; Brescia F; Proscia P; Falco C; Carassiti M
    J Surg Oncol; 2014 Apr; 109(5):500-3. PubMed ID: 24310214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.